Target intelligence / Profile preview

RNA, U6 small nuclear 1111, pseudogene (RNU6-1111P)

Target
RNU6-1111P
Molecular classification
Pseudogene, Non-coding RNA (ancestral: small nuclear RNA)
01

Overview

**RNU6-1111P** is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, which are found throughout the vertebrate genome as relics of retrotransposition events[5]. While functional U6 snRNA is an essential component of the major spliceosome—a cellular complex responsible for the splicing of pre-mRNA—pseudogenes like RNU6-1111P do not encode active snRNA or have any functional activity in splicing or cellular processes[3][5]. Their presence is attributed to L1-mediated retrotransposition, a process that copies RNA sequences back into the genome, thereby creating non-functional, typically truncated, gene “copies.” These pseudogenes serve as genomic markers for retrotransposition activity and evolutionary processes but do not possess biological or therapeutic function[5]. **Key notes:** - RNU6-1111P should **not** be considered a drug target, receptor, enzyme, or disease marker. - The core U6 snRNA gene (not pseudogenes) is functionally crucial for RNA splicing, but pseudogenes like RNU6-1111P are inactive[1][3][5]. If "RNU6-1111P" is being considered as a target in any context, this is **incorrect** based on current molecular biology understanding, as it is an inactive genomic element with no known physiological or pathological function[2][4][5].

Other names
RNU6-1111P
02

Mechanism of action

None (not a therapeutic target; no active mechanisms)

03

Biological functions

None (RNU6-1111P is a non-functional, processed pseudogene and does not have a direct biological function[2][4][5])
04

Disease associations

None (no established disease roles; pseudogenes generally do not have roles in pathology unless co-opted or dysregulated, which has not been reported for RNU6-1111P)
05

Safety considerations

None (not a target for therapy; no safety concerns described)
06

Interacting drugs

None (there are no drugs targeting pseudogenes of U6 snRNA[2][5])
07

Biomarkers

None (no utility as a biomarker has been reported)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1111, pseudogene (RNU6-1111P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1111, pseudogene (RNU6-1111P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call